why choose us

First received: November 02, 2023

Clinical Trial: Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Metastatic Uveal Melanoma

Study Type: INTERVENTIONAL


Official Title: A Phase II Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

Brief Summary: The goal of this clinical research study is to find out if Cemiplimab plus Ziv-Aflibercept is safe and effective in treating your condition of metastatic (spread to other parts of your body) uveal melanoma.This research study will test the study drugs to see if the combination of Cemiplimab plus Ziv-Aflibercept can make tumors shrink or stop growing.

Read more